Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Pharmacy

 

UK pharmacists given green light to prescribe as primary care can’t cope

Pharmacists in the UK now have the right to prescribe for common ailments such as sore throats and earaches. In France, Ireland and Portugal pharmacists also have some prescribing rights and similar initiatives may be introduced in other European countries in the near future. Is this a solution to the GP workforce shortage? And will it be a good thing for private hospital and private primary care groups?

Ardian to buy France’s largest pharmacy chain and make it multinational

French PE firm Ardian has entered into exclusive negotiations to buy France's largest pharmacy chain, Aprium Pharmacie, from North American PE firm Sagard. Ardian plans to develop Aprium's advisory and digital offering, and to expand the group outside of France. We speak to Ardian's head of growth to find out more.

Aster DM sells majority stake in Gulf business for $1bn

Dubai-based listed hospital and pharmacy chain Aster DM is selling a majority 65% stake in its Gulf business for a shade over $1bn to a consortium led by PE investor Fajr Capital. HBI investigates the thinking behind the deal, what this means for the group's expansion plans, and looks at the future of the GCC market generally with the help of expert commentary. 

Fresenius: “We’re not selling”

Germany-based healthcare conglomerate Fresenius tells HBI it isn't currently looking to carve off parts of its business for sale, and despite mixed H1 results it sees plenty of opportunities for growth.

HBI 2022: Balance of power in MENA is shifting

There is a risk, when looking at healthcare markets in MENA, of lumping all the countries together as one - but each market has very specific requirements, and very specific characteristics. A panel at HBI 2022 chaired by Hamid Yunis, partner at global law firm McDermott Will & Emery, investigated challenges and opportunities in the region - and how rapidly the markets are changing and why overseas players now need to work harder to impress.

Interview: Zeinab Ardeshir, CEO, PillSorted

Zeinab Ardeshir has worked in pharmacy for 17 years in multiple countries, but although she has generally enjoyed this experience, she found that a lot of her time was spent on mundane repetitive tasks which seemed like a waste for someone with her medical knowledge.

German government pushing ahead with cannabis legalisation

The German health minister is pressing ahead with plans to legalise cannabis, despite concerns from some quarters that it could be challenged at the EU level, and unresolved questions about what the regulatory framework will look like. HBI speaks to legal and policy experts, and hears that medical cannabis producers have an early adopter advantage against potential rivals - and there are health implications if legislation passes.

Find Us